DR. REDDY'S LABORATORIES-ADR (RDY)

US2561352038 - ADR

15.37  +0.25 (+1.65%)

After market: 15.27 -0.1 (-0.65%)

DR. REDDY'S LABORATORIES-ADR

NYSE:RDY (12/20/2024, 8:04:00 PM)

After market: 15.27 -0.1 (-0.65%)

15.37

+0.25 (+1.65%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-96.62%
Sales Q2Q%16.45%
CRS63.89
6 Month7.39%
Overview
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)01-28 2025-01-28/bmo
Ins Owners21.85%
Inst Owners49.28%
Market Cap12.80B
Shares833.07M
PE6.77
Fwd PE18
Dividend Yield0.6%
Analysts56.59
Short Float %N/A
Short Ratio13.51
IPO01-01 1986-01-01
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

RDY Daily chart

Company Profile

Dr Reddy's Laboratories Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Hyderabad, Telangana and currently employs 26,343 full-time employees. Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Company Info

DR. REDDY'S LABORATORIES-ADR

8-2-337, Road No.3 Banjara Hills

Hyderabad TELANGANA 500-034

P: 914049002900

CEO: Erez Israeli

Employees: 27048

Website: https://www.drreddys.com/

RDY Twits

Here you can normally see the latest stock twits on RDY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example